ALS Research: Experiments Show Potential for New Treatment

Marta Ribeiro avatar

by Marta Ribeiro |

Share this article:

Share article via email

Dr. Joe Beckman, PhD, at the Oregon State University, has been studying the chemistry of amyotrophic lateral sclerosis for quite a while. Together with other researchers, Dr. Beckman has been able to demonstrate a treatment which can dramatically extend the survival rate of laboratory mice who have been engineered to develop ALS. Watch the video to learn more about this discovery.

Read the latest updates on ALS: https://bit.ly/ALSNewsToday

ALS News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Print This Page

About the Author

Marta Ribeiro avatar
Marta Ribeiro Marta graduated from Universidade Fernando Pessoa in Porto with a degree in Communication Sciences and a Masters degree in New Communication Technologies. She has experience in social media, worked with several media channels, and has also worked as a freelance photographer and a graphic artist for almost 10 years.

Tags

ALS, ALS Research, amyotrophic lateral sclerosis (ALS)

Recent Posts


Recommended reading